These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2777410)

  • 1. HMFG1 antigen: a new marker for carcinomatous meningitis.
    Moseley RP; Oge K; Shafqat S; Moseley CM; Sullivan NM; Badley RA; Burchell J; Taylor-Papadimitriou J; Coakham HB
    Int J Cancer; 1989 Sep; 44(3):440-4. PubMed ID: 2777410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
    Kosmas C; Tsavaris NB; Soukouli G; Gouveris P; Tsakonas G; Katselis J; Alexopoulos H; Mylonakis N; Karabelis A
    Med Oncol; 2005; 22(2):123-8. PubMed ID: 15965274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical demonstration of carcinoembryonic antigen in cerebrospinal fluid with carcinomatous meningitis from rectal cancer.
    Kobayashi TK; Yamaki T; Yoshino E; Higuchi T; Kamachi M
    Acta Cytol; 1984; 28(4):430-4. PubMed ID: 6380184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
    van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis.
    Klee GG; Tallman RD; Goellner JR; Yanagihara T
    Mayo Clin Proc; 1986 Jan; 61(1):9-13. PubMed ID: 3510343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis.
    Hovestadt A; Henzen-Logmans SC; Vecht CJ
    Br J Cancer; 1990 Oct; 62(4):653-4. PubMed ID: 2223585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors.
    Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
    J Neurooncol; 1992 Feb; 12(2):111-20. PubMed ID: 1560255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.
    Galicia N; Díez P; Dégano RM; Guest PC; Ibarrola N; Fuentes M
    Adv Exp Med Biol; 2017; 974():85-96. PubMed ID: 28353226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis.
    Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z
    Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid gastrin releasing peptide in the diagnosis of leptomeningeal metastases from small cell carcinoma.
    Castro MP; McDonald TJ; Qualman SJ; Odorisio TM
    Cancer; 2001 Jun; 91(11):2122-6. PubMed ID: 11391593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF carcinoembryonic antigen in meningeal carcinomatosis from breast cancer.
    Yap BS; Yap HY; Fritsche HA; Blumenschein G; Bodey GP
    JAMA; 1980 Oct; 244(14):1601-3. PubMed ID: 7420663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer.
    Bach F; Soletormos G; Dombernowsky P
    J Natl Cancer Inst; 1991 Jun; 83(11):779-84. PubMed ID: 2041052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual presentation of carcinomatous meningitis: case report and review of typical CSF findings.
    Zeller JA; Zunker P; Witt K; Schlueter E; Deuschl G
    Neurol Res; 2002 Oct; 24(7):652-4. PubMed ID: 12392200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinomatous meningitis revealing a cancer: study of two cases].
    Samet S; Belahsen F; Triki C; Masmoudi H; Jlidi R; Mhiri C
    Tunis Med; 2001 Apr; 79(4):257-60. PubMed ID: 11515489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinomatous meningitis: antibody-guided therapy with I-131 HMFG1.
    Moseley RP; Benjamin JC; Ashpole RD; Sullivan NM; Bullimore JA; Coakham HB; Kemshead JT
    J Neurol Neurosurg Psychiatry; 1991 Mar; 54(3):260-5. PubMed ID: 2030355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptomeningeal carcinomatosis.
    Grossman SA; Krabak MJ
    Cancer Treat Rev; 1999 Apr; 25(2):103-19. PubMed ID: 10395835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis.
    Stockhammer G; Poewe W; Burgstaller S; Deisenhammer F; Muigg A; Kiechl S; Schmutzhard E; Maier H; Felber S; Schumacher P; Gunsilius E; Gastl G
    Neurology; 2000 Apr; 54(8):1670-6. PubMed ID: 10762512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancer.
    Bach F; Bach FW; Pedersen AG; Larsen PM; Dombernowsky P
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1703-9. PubMed ID: 2632253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carcinomatous meningitis presenting with isolated headache].
    Outteryck O; Berteloot D; Senechal O; Fromentin C; Mounier-Vehier F
    Rev Neurol (Paris); 2004 Oct; 160(10):949-51. PubMed ID: 15492724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid biochemical markers of central nervous system metastases.
    Schold SC; Wasserstrom WR; Fleisher M; Schwartz MK; Posner JB
    Ann Neurol; 1980 Dec; 8(6):597-604. PubMed ID: 7212647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.